WPI 3620 (Armodafinil 50 mg)
Pill with imprint WPI 3620 is White, Round and has been identified as Armodafinil 50 mg. It is supplied by Watson Laboratories, Inc. .
Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; chronic fatigue syndrome; obstructive sleep apnea/hypopnea syndrome; bipolar disorder (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3620
Armodafinil
- Imprint:
- WPI 3620
- Strength:
- 50 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-3620
More about armodafinil
- Armodafinil Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 286 Reviews – Add your own review/rating
- Drug class: CNS stimulants
Consumer resources
Other brands: Nuvigil
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
